Bristol-Myers Squibb Company Ce

CELG-RI•United States

Healthcare United States Pharmaceutical Preparations

Need professional-grade analysis? Visit stockanalysis.com

$0.08

-13.03%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	—	—	0.69	—	0.69
Calmar	—	—	—	—	1.56	—	1.56
Sharpe	—	—	—	—	0.40	—	0.40
Omega	—	—	—	—	1.33	—	1.33
Martin	—	—	—	—	3.39	—	3.39
Ulcer	—	—	—	—	29.61	—	29.61

Bristol-Myers Squibb Company Ce (CELG-RI) Price Performance

Bristol-Myers Squibb Company Ce (CELG-RI) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.08, down 13.03% from the previous close.

Over the past year, CELG-RI has traded between a low of $0.02 and a high of $0.21. The stock has gained 175.3% over this period. It is currently 61.8% below its 52-week high.

Company Info

Sector: Healthcare
Industry: Pharmaceutical Preparations
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: $0.27
52 Week Low: $0.02
50 Day MA: $0.12
200 Day MA: $0.06
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A

Bristol-Myers Squibb Company Ce

Price Chart

Risk-Adjusted Performance

Bristol-Myers Squibb Company Ce (CELG-RI) Price Performance

Company Info

Financial Metrics

Technical Indicators

Valuation

Bristol-Myers Squibb Company Ce

Price Chart

Risk-Adjusted Performance

Bristol-Myers Squibb Company Ce (CELG-RI) Price Performance

Company Info

Financial Metrics

Technical Indicators

Valuation

Compare Bristol-Myers Squibb Company Ce